Issue 1, 2013

On the importance of synthetic organic chemistry in drug discovery: reflections on the discovery of antidiabetic agent ertugliflozin§

Abstract

The discovery of antidiabetic agent ertugliflozin is described. The compound belongs to a new class of SGLT2 inhibitors bearing a dioxa-bicyclo[3.2.1]octane motif. This article describes the critical role that organic synthesis played in both influencing our medicinal chemistry strategy and speeding up the progression of our program.

Graphical abstract: On the importance of synthetic organic chemistry in drug discovery: reflections on the discovery of antidiabetic agent ertugliflozin

Supplementary files

Article information

Article type
Concise Article
Submitted
24 Jun 2012
Accepted
11 Jul 2012
First published
16 Jul 2012

Med. Chem. Commun., 2013,4, 101-111

On the importance of synthetic organic chemistry in drug discovery: reflections on the discovery of antidiabetic agent ertugliflozin

V. Mascitti, B. A. Thuma, A. C. Smith, R. P. Robinson, T. Brandt, A. S. Kalgutkar, T. S. Maurer, B. Samas and R. Sharma, Med. Chem. Commun., 2013, 4, 101 DOI: 10.1039/C2MD20163A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements